New vaccine technology could protect from future viruses and variants

The vaccine antigen technology, developed by the University of Cambridge and spin-out DIOSynVax in early 2020, provided protection against all known variants

Related Keywords

Ankara ,Turkey ,United Kingdom ,Cambridge ,Cambridgeshire ,Jonathan Heeney ,Darwin College ,United Kingdom Vaccine Network ,University Of Cambridge ,Cambridge Department Of Veterinary Medicine ,Clinical Research Facilities ,University Of Regensburg ,Digitally Immune Optimised Synthetic Vaccines ,Nature Biomedical ,Professor Jonathan Heeney ,Veterinary Medicine ,Modified Vaccinia Ankara ,Kingdom Vaccine Network ,Innovate United Kingdom ,Cambridge Enterprise ,Comparative Pathology ,Innovate Uk ,Iosynvax Diosynvax ,Nnovate Uk Jonathan Heeney Animal Research ,Coronavirus ,Covid 19 ,Uture Therapeutics ,Infectious Diseases ,Accine Infectious Diseases ,Vaccine ,Nimal Research Cambridge Enterprise ,Cambridge Infectious Diseases ,Laboratory Of Viral Zoonotics ,School Of The Biological Sciences ,Epartment Of Veterinary Medicine Department ,